Survival Motor Neuron-2-directed RNA Interaction

All categories
Name
Survival Motor Neuron-2-directed RNA Interaction
Accession Number
DBCAT003544
Description

Not Available

Drugs
DrugDrug Description
NusinersenA medication used to treat spinal muscular atrophy.
RisdiplamAn oral mRNA splicing modifier used in the treatment of spinal muscular atrophy (SMA).
Drugs & Drug Targets
DrugTargetType
NusinersenSurvival motor neuron proteintarget
RisdiplamP-glycoprotein 1transporter
RisdiplamATP-binding cassette sub-family G member 2transporter
RisdiplamMultidrug and toxin extrusion protein 1transporter
RisdiplamMultidrug and toxin extrusion protein 2transporter
RisdiplamCytochrome P450 3A Subfamilyenzyme
RisdiplamDimethylaniline monooxygenase [N-oxide-forming] 1enzyme
RisdiplamDimethylaniline monooxygenase [N-oxide-forming] 3enzyme
RisdiplamCytochrome P450 1A1enzyme
RisdiplamCytochrome P450 2J2enzyme
RisdiplamCytochrome P450 3A4enzyme
RisdiplamCytochrome P450 3A7enzyme
RisdiplamSerum albumincarrier